Searched for
AUROBINDO PHARMA DIRECTOR
Flexi cap fund inflows halve to Rs 5,175 crore in May after record April. Is this profit booking or a buying opportunity?Flexi cap fund inflows dropped 49% in May to Rs 5,175 crore after April’s record surge, reflecting broader moderation across equity categor...- Aurobindo Pharma arm CuraTeQ gets Health Canada nod for biosimilarAurobindo Pharma announced a significant development today. Its subsidiary, CuraTeQ Biologics, has received a compliance notice from Health...
- Another buyback offer coming soon! This time it's from Bajaj AutoBajaj Auto has announced that its board will consider a share buyback proposal on May 6, 2026, signalling plans to return surplus cash to s...
- Share buybacks this month: Wipro, Aurobindo Pharma, 2 other stocks to watch out forFour companies—Wipro, Cyient, Windlas Biotech, and Aurobindo Pharma—are set to announce or act on share buybacks this month, with Aurobindo...
- Stocks in news: Torrent Power, GAIL, J&K Bank, Ola Electric, Vedanta, InfosysMarkets ended higher for the third consecutive session amidst volatility. Today's trade will focus on ceasefire developments and the MPC me...
- Aurobindo Pharma eyes $5-B revenue in 5 yearsAurobindo Pharma has undergone a significant reorganisation, restructuring its operations into three subsidiaries. Eugia Pharma Specialitie...
- Aurobindo stock faces stress due to governance concernsThis despite the company informing stock exchanges that the arrest is not in any way connected with its operations or those of its subsidia...
- Director's arrest no way linked to operations: Aurobindo Pharma"Further to the disclosure of even date, the company further learnt that the arrest of P Sarath Chandra Reddy, whole-time director/promoter...
- Aurobindo Pharma Managing Director N Govindarajan resigns"His resignation was considered and accepted by the board of directors in its meeting today. N Govindarajan will be relieved from the servi...
- Aurobindo Pharma completes sale of Natrol LLC to New Mountain CapitalNatrol's annual sales for the 12 months ended March 31, 2020, stood at around USD 157 million.
- Aurobindo ties up with Biotechnology Industry Research Assistance Council for COVID-19 vaccineAurobindo Pharma said it is developing a vaccine for COVID-19 through its wholly-owned US subsidiary, Auro Vaccines. The vaccine candidate ...
- Aurobindo Pharma says co, subsidiary made party to litigation proceeding in USThe drug firm in a regulatory filing however said it is yet to receive a copy of the proceeding and denied what it said were 'baseless alle...
- Aurobindo Pharma arm enters pact to form JV in China with Luoxin"The percentage of shareholding in the joint venture company will be 30 per cent and 70 per cent between Helix and Luoxin," Aurobindo Pharm...
- Wait for one more quarter before buying into Aurobindo Pharma: Harendra Kumar"The volatility in Aurobindo has not been to the investor's comfort so, they will wait for one more quarter before actually they will start...
- Sell Aurobindo Pharma with a target price of Rs 138: Deepak Mohoni"Aurobindo Pharma is a sell call with a target price of Rs 138 and stop loss of Rs 143."
- Buy Aurobindo Pharma with a target of 181: Deepak MohoniAurobindo Pharma is a buy with a stop loss of 171.5 and a target of 181.
- Aurobindo Pharma is a pretty volatile stock: Deepak MohoniAurobindo Pharma made a good move from late February. Now it is going a little bit sideways between Rs 185 and Rs 210.
- Aurobindo Pharma has been a bit of a laggard: Deepak MohoniIf you consider the gains made by various other stocks, this stock has been a bit of a laggard.
- Aurobindo Pharma's longer term trend turned down: Deepak MohoniAurobindo falls in the vulnerable category of pharma stocks.
- Strides Arcolab & Aurobindo Pharma are good stocks to own: Satish BetadpurSatish Betadpur, CFA, Global Research Director, Independent International Investment Research PLC in an interview with ET Now talks about S...
Load More
